Institut Pasteur Korea

Institut National De La Sante Et De La Recherche Medicale

Qurient Co., Ltd.

Zaesung No

Jaeseung Kim

SaeYeon Lee

Sunhee Kang

Min Jung Seo

Priscille Brodin

Auguste Genovesio

Denis Philippe Cedric Fenistein

Thierry Christophe

Ji Youn Nam

Heekyoung Jeon

Fanny Anne Ewann

Young Sam Park

Young Mi Kim

Jinhwa Lee

Sangchul Lee

Kiyean Nam

Jeongjun Kim

Sung-Jun Han

Gahee Choi

Jung Hwan Kim

Eun Hye Kim

Monica Contreras Dominguez

Eunjung Park

Jang Jiyeon

Jamung Heo

Jonathan Cechetto

Heo Jamung

Denis Philippe Fenistein

Priscille Brodin Brodin

The present invention refers to: a compound having the general formula (I), wherein n is 0, 1, 2 or; m is 0, 1, 2 or 3; o is 0, 1, 2 or 3; W, X, Y and Z are independently selected from CH, N or N-oxide; A is NR, C&#x2550;O, C&#x2550;S, OP(O)(O), P&#x2550;O, CH2, or a heteroarly selected from the group consisting of (a), (b), (c), (d), (e), (f), (g); V is C&#x2550;O, O, S, CH, or NR; as well as its use in treating inflammatory diseases such as asthma, COPD, inflammation post infection, arthritis, atherosclerosis, pain and dermatitis. 

Anti-inflammation compounds

The present invention relates to small molecule compounds and their use in the treatment of bacterial infections, in particular Tuberculosis.

Anti-infective compounds

The present invention relates to 4H-pyrido[1,2-a]pyrimidin-4-one compounds and their use in the treatment of bacterial infections, in particular Tuberculosis.

Growing community of inventors

Gyeonggido, South Korea

Zaesung No